Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Mol Biol ; 352(5): 1134-56, 2005 Oct 07.
Article in English | MEDLINE | ID: mdl-16139843

ABSTRACT

Inhibition of protein kinase activity is a focus of intense drug discovery efforts in several therapeutic areas. Major challenges facing the field include understanding of the factors determining the selectivity of kinase inhibitors and the development of compounds with the desired selectivity profile. Here, we report the analysis of sequence variability among high and low affinity targets of eight different small molecule kinase inhibitors (BIRB796, Tarceva, NU6102, Gleevec, SB203580, balanol, H89, PP1). It is observed that all high affinity targets of each inhibitor are found among a relatively small number of kinases, which have similar residues at the specific positions important for binding. The findings are highly statistically significant, and allow one to exclude the majority of kinases in a genome from a list of likely targets for an inhibitor. The findings have implications for the design of novel inhibitors with a desired selectivity profile (e.g. targeted at multiple kinases), the discovery of new targets for kinase inhibitor drugs, comparative analysis of different in vivo models, and the design of "a-la-carte" chemical libraries tailored for individual kinases.


Subject(s)
Amino Acids/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Kinases/metabolism , Thermodynamics , Amino Acid Sequence , Amino Acids/genetics , Benzamides , Binding Sites/drug effects , Binding Sites/genetics , Humans , Imatinib Mesylate , Ligands , Molecular Sequence Data , Piperazines/chemistry , Piperazines/pharmacology , Protein Binding/drug effects , Protein Binding/genetics , Protein Kinase Inhibitors/chemistry , Protein Kinases/chemistry , Protein Kinases/genetics , Pyrazoles/chemistry , Pyrazoles/pharmacology , Pyrimidines/chemistry , Pyrimidines/pharmacology , Sequence Alignment , Static Electricity
2.
J Mol Biol ; 334(4): 823-41, 2003 Dec 05.
Article in English | MEDLINE | ID: mdl-14636606

ABSTRACT

Here, we present an approach for the prediction of binding preferences of members of a large protein family for which structural information for a number of family members bound to a substrate is available. The approach involves a number of steps. First, an accurate multiple alignment of sequences of all members of a protein family is constructed on the basis of a multiple structural superposition of family members with known structure. Second, the methods of continuum electrostatics are used to characterize the energetic contribution of each residue in a protein to the binding of its substrate. Residues that make a significant contribution are mapped onto the protein sequence and are used to define a "binding site signature" for the complex being considered. Third, sequences whose structures have not been determined are checked to see if they have binding-site signatures similar to one of the known complexes. Predictions of binding affinity to a given substrate are based on similarities in binding-site signature. An important component of the approach is the introduction of a context-specific substitution matrix suitable for comparison of binding-site residues. The methods are applied to the prediction of phosphopeptide selectivity of SH2 domains. To this end, the energetic roles of all protein residues in 17 different complexes of SH2 domains with their cognate targets are analyzed. The total number of residues that make significant contributions to binding is found to vary from nine to 19 in different complexes. These energetically important residues are found to contribute to binding through a variety of mechanisms, involving both electrostatic and hydrophobic interactions. Binding-site signatures are found to involve residues in different positions in SH2 sequences, some of them as far as 9A away from a bound peptide. Surprisingly, similarities in the signatures of different domains do not correlate with whole-domain sequence identities unless the latter is greater than 50%. An extensive comparison with the optimal binding motifs determined by peptide library experiments, as well as other experimental data indicate that the similarity in binding preferences of different SH2 domains can be deduced on the basis of their binding-site signatures. The analysis provides a rationale for the empirically derived classification of SH2 domains described by Songyang & Cantley, in that proteins in the same group are found to have similar residues at positions important for binding. Confident predictions of binding preference can be made for about 85% of SH2 domain sequences found in SWISSPROT. The approach described in this work is quite general and can, in principle, be used to analyze binding preferences of members of large protein families for which structural information for a number of family members is available. It also offers a strategy for predicting cross-reactivity of compounds designed to bind to a particular target, for example in structure-based drug design.


Subject(s)
Phosphopeptides/chemistry , Phosphopeptides/metabolism , src Homology Domains , Amino Acid Sequence , Binding Sites , Molecular Sequence Data , Peptide Library , Protein Binding , Sequence Alignment , Substrate Specificity
3.
J Mol Biol ; 318(1): 161-77, 2002 Apr 19.
Article in English | MEDLINE | ID: mdl-12054776

ABSTRACT

Here, the methods of continuum electrostatics are used to investigate the contribution of electrostatic interactions to the binding of four protein-protein complexes; barnase-barstar, human growth hormone and its receptor, subtype N9 influenza virus neuraminidase and the NC41 antibody, the Ras binding domain (RBD) of kinase cRaf and a Ras homologue Rap1A. In two of the four complexes electrostatics are found to strongly oppose binding (hormone-receptor and neuraminidase-antibody complexes), in one case the net effect is close to zero (barnase-barstar) and in one case electrostatics provides a significant driving force favoring binding (RBD-Rap1A). In order to help understand the wide range of electrostatic contributions that were calculated, the electrostatic free energy was partitioned into contributions of individual charged and polar residues, salt bridges and networks involving salt bridges and hydrogen bonds. Although there is no one structural feature that accounts for the differences between the four interfaces, the extent to which the desolvation of buried charges is compensated by the formation of hydrogen bonds and ion pairs appears to be an important factor. Structural features that are correlated with contribution of an individual residue to stability are also discussed. These include partial burial of a charged group in the free monomer, the formation of networks involving charged and polar amino acids, and the formation of partially exposed ion-pairs. The total electrostatic contribution to binding is found to be inversely correlated with buried total and non-polar surface area. This suggests that different interfaces can be designed to exploit electrostatic and hydrophobic forces in very different ways.


Subject(s)
Bacterial Proteins/chemistry , Human Growth Hormone/chemistry , Neuraminidase/chemistry , Proto-Oncogene Proteins c-raf/chemistry , Receptors, Somatotropin/chemistry , rap1 GTP-Binding Proteins/chemistry , Antigen-Antibody Reactions , Bacterial Proteins/metabolism , Binding Sites , Drug Stability , Histidine/chemistry , Human Growth Hormone/metabolism , Humans , Hydrogen Bonding , Ions , Mathematics , Neuraminidase/metabolism , Orthomyxoviridae/enzymology , Protein Binding , Protein Structure, Tertiary , Proto-Oncogene Proteins c-raf/metabolism , Receptors, Somatotropin/metabolism , Static Electricity , Thermodynamics , rap1 GTP-Binding Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...